Skip to Content

Newsletter No. 67 -- October 2003

FROM: Cancer Imaging Program, National Cancer Institute, October, 2003.

CIP Web Site: http://cip.cancer.gov/

CANCER IMAGING PROGRAM is our new name. 

Meetings
PRECLINICAL TRIALS IN BREAST CANCER, NOVEMBER 1-5, 2003
Sacramento Convention Center in Sacramento, CA
Sponsored by MMHCC's Committees for Mammary Gland Cancer and
Pathology and Laboratory Medicine and the International Association for Breast Cancer Research
Meeting registration and information: http://cme.ucdavis.edu/confrnce/IABCR/email2.html
Organizer: Robert Cardiff (rdcardiff@ucdavis.edu)

AACR/NCI/EORTC MOLECULAR TARGETS AND CANCER THERAPEUTICS 
Conference to be held November 17-21, 2003, in Boston, Massachusetts. 
URL: http://www.aacr.org/2003mtct.asp

RSNA - RADIOLOGIC SOCIETY OF NORTH AMERICA
89th Scientific Assembly and Annual Meeting, Nov. 30 - Dec. 5, 2003, McCormick Place, 
Chicago, Illinois
URL: http://www.rsna.org

5TH NATIONAL FORUM ON BIOMEDICAL IMAGING IN ONCOLOGY
January 29-30, 2004, Hyatt Regency Bethesda, Bethesda, MD
URL: http://cancer.gov/dctd/forum

SPIE INTERNATIONAL SYMPOSIUM: MEDICAL IMAGING 2004
14 - 19 February 2004, Town & Country Hotel, San Diego, CA
URL: http://www.spie.org

ACADEMY OF MOLECULAR IMAGING ANNUAL MEETING
The Academy of Molecular Imaging announces that it is now accepting abstract submissions for the 2004 AMI Annual Conference, to be held March 28-31, 2004, at the Gaylord Palms Resort and Convention Center in Orlando, Florida. 
URL: http://www.ami-imaging.org

Announcement
The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof?of?principle clinical trials. See the web site for details.
URL: http://www3.cancer.gov/bip/dcide.htm

NIH
1. SMALL ANIMAL IMAGING RESOURCE PROGRAMS(NCI)(CA-04-011)
LETTER OF INTENT RECEIPT DATE: November 18, 2003 
APPLICATION RECEIPT DATE: December 18, 2003 
The National Cancer Institute (NCI) invites applications from extramural investigators for Small Animal Imaging Resource Programs (SAIRPs). These grants will support (a) shared imaging research resources to be used by cancer investigators, (b) research related to small animal imaging technology, and (c) training of both professional and technical support personnel interested in the science and techniques of small animal imaging. 
URL: http://grants1.nih.gov/grants/guide/rfa-files/RFA-CA-04-011.html

2. THE EARLY DETECTION RESEARCH NETWORK: Biomarker Developmental Laboratories
(NCI) (RFA-CA-04-006)
LETTER OF INTENT RECEIPT DATE: December 23, 2003 
APPLICATION RECEIPT DATE: January 23, 2004 
The Division of Cancer Prevention (DCP), National Cancer Institute (NCI), invites new and competing renewal cooperative agreement and NIH intramural applications to continue the national Network that has the responsibility for the development, evaluation, and validation of biomarkers for earlier cancer detection and risk assessment. 
URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-04-006.html

3. NIH SUPPORT FOR CONFERENCES AND SCIENTIFIC MEETINGS (PAR-03-176)
Please Note Changes: 1) 3 Standard Receipt Dates- April 15, August 15, December 15; 
2) Requirement for the PI to attach an acceptance letter from Institute point-of-contact 
(Florence Pedersen), affirming that program staff has agreed to accept the application.
URL: http://grants.nih.gov/grants/guide/pa-files/PAR-03-176.html

4. GUIDELINES FOR INCLUSION OF WOMEN, MINORITIES, AND PERSONS WITH DISABILITIES IN NIH-SUPPORTED CONFERENCE GRANTS (NOT-OD-03-066)
This Notice provides updated policy regarding the inclusion of women, minorities, and persons with disabilities in conference grants supported by the National Institutes of Health (NIH).
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-066.html

5. EXPLORATORY CENTERS (P20) FOR INTERDISCIPLINARY RESEARCH (NCRR/NIH)
(RFA-RR-04-002)
LETTER OF INTENT RECEIPT DATE: January 30, 2004 
APPLICATION RECEIPT DATE: February 24, 2004 
This RFA invites applications for planning grants using the P20 (exploratory center) mechanism that will focus on developing new approaches to solving significant and complex biomedical problems, particularly those that have been resistant to more traditional approaches. These new approaches must hold the promise of leading to new research approaches to improving human health. These planning grants are expected to identify a biomedically relevant problem, evaluate why previous approaches have not worked, justify why the proposed interdisciplinary approach will work, identify the planning approach, and propose a timeline. This RFA is developed as a roadmap initiative.
URL: http://grants1.nih.gov/grants/guide/rfa-files/RFA-RR-04-002.html

6. NATIONAL TECHNOLOGY CENTERS FOR NETWORKS AND PATHWAYS (NCRR, NIH)
(RFA-RR-04-003)
LETTER OF INTENT RECEIPT DATE: February 15, 2004 
APPLICATION RECEIPT DATE: March 16, 2004 
These centers will cooperate in a networked national effort to develop highly novel, integrated, and broadly applicable proteomics technologies, to include instrumentation, biophysical methods, reagents, and infrastructure. These technologies will be specifically directed at the fundamental technological challenges inherent in acquiring quantitative information at the high anatomic resolution (subcellular) and biologically relevant timescales necessary for temporal and spatial characterization of complex biochemical pathways and molecular interactions. Beyond cataloging of proteins and their binary interactions, these methods will be directed toward quantitatively defining the dynamics of complex systems. The establishment of the TCNPs was called for in the NIH Roadmapping Initiative in 2003. TCNPs will be supported by U54 awards. 
URL: http://grants1.nih.gov/grants/guide/rfa-files/RFA-RR-04-003.html

_______________________
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.

If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (js95x@nih.gov).

Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507